Next Article in Journal
Novel Conformationally Constrained Analogues of Agomelatine as New Melatoninergic Ligands
Previous Article in Journal
Cytotoxic and Antioxidant Compoundsfrom the Stem Bark of Goniothalamus tapisoides Mat Salleh
Article Menu

Export Article

Open AccessArticle
Molecules 2013, 18(1), 140-153; doi:10.3390/molecules18010140

Inhibitory Evaluation of Sulfonamide Chalcones on β-Secretase and Acylcholinesterase

Division of Applied Life Science (BK21 Program), IALS, Gyeongsang National University, Jinju 660-701, Korea
Graduate Program in Biochemistry and Biophysics, Brandeis University, 415 South Street, Waltham, MA 02453, USA
Chemical Safety Division, National Academy of Agricultural Sciences, RDA, Suwon 441-701, Korea
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 19 November 2012 / Revised: 16 December 2012 / Accepted: 18 December 2012 / Published: 21 December 2012
Download PDF [308 KB, uploaded 18 June 2014]


The action of β-secretase (BACE1) is strongly correlated with the onset of Alzheimer’s disease (AD). Aminochalcone derivatives were examined for their ability to inhibit BACE1. Parent aminochalcones showed two digit micromolar IC50s against BACE1. Potency was enhanced 10-fold or more by introducing benzenesulfonyl derivatives to the amino group: 1 (IC50 = 48.2 μM) versus 4a (IC50 = 1.44 μM) and 2 (IC50 = 17.7 μM) versus 5a (IC50 = 0.21 μM). The activity was significantly influenced by position and number of hydroxyl groups on the chalcone B-ring: 3,4-dihydroxy 5a (IC50 = 0.21 μM) > 4-hydroxy 4a (IC50 = 1.44 μM) > 2,4-dihydroxy 6 (IC50 = 3.60 μM) > 2,5-dihydroxy 7 (IC50 = 16.87 μM) > des hydroxy 4b (IC50 = 168.7 μM). Lineweaver-Burk and Dixon plots and their secondary replots indicate that compound 5a was a mixed inhibitor with reversible and time-dependent behavior. Potent BACE1 inhibitors 4a,c,f, 5ac showed moderate inhibition against two other enzymes implicated in AD pathogenesis, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), with IC50s ranging between 56.1 ~ 95.8 μM and 19.5 ~ 79.0 μM, respectively.
Keywords: sulfonamide chalcone; Alzheimer’s disease (AD); β-secretase; acetylcholinesterase (AChE); butyrylcholinesterase (BChE); mixed inhibition sulfonamide chalcone; Alzheimer’s disease (AD); β-secretase; acetylcholinesterase (AChE); butyrylcholinesterase (BChE); mixed inhibition
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Kang, J.E.; Cho, J.K.; Curtis-Long, M.J.; Ryu, H.W.; Kim, J.H.; Kim, H.J.; Yuk, H.J.; Kim, D.W.; Park, K.H. Inhibitory Evaluation of Sulfonamide Chalcones on β-Secretase and Acylcholinesterase. Molecules 2013, 18, 140-153.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top